J&J’s $10 Billion Settlement Rejected: Ripple Effects on Insurance and Risk Management Johnson & Johnson’s latest attempt to settle over 60,000 lawsuits with a $10 billion bankruptcy plan has hit yet another wall. It’s the third time courts have rejected the healthcare giant’s “Texas two-step” bankruptcy strategy, leaving both legal experts and insurance professionals buzzing. But this isn’t just corporate news; the ruling sends shockwaves through liability insurance and risk management landscapes, raising questions about how companies handle legal exposure in a litigious era. Legal Setback: Understanding the Judge’s Decision…
Read MoreTag: Johnson & Johnson
New York charges Johnson & Johnson with opioid claim insurance fraud
The state filed civil charges at the end of last week, accusing the firm of downplaying risks. Last week, the state of New York filed civil charges against Johnson & Johnson of opioid claim insurance fraud. It accused the company of downplaying the risks associated with these painkiller medications, including to patients who are elderly. Governor Cuomo said the charges follow a probe conducted by the state regulator. New York Governor Andrew Cuomo said the opioid claim insurance fraud charges by the state’s Department of Financial Services result from that…
Read More